Clinical trial interim results of SCG101 shows tumour control with lesion shrinkage observed in two out of three patients with advanced HBV-related HCC Results show rapid and significant serum HBsAg reduction indicates signal of antiviral activity Data presented support the advancement of…
SCG Cell Therapy Presents Clinical Proof-of-Concept Data at International Liver Congress (ILC) 2022 Annual Meeting
